Henry Schein, Inc.
NASDAQ:HSICMedical - Distribution
-$1.24 today
- Market cap
- $9.47B
- Beta
- 0.82
- P/E (TTM)
- 23.3
- EPS (TTM)
- $3.44
Volume 2.08M
Average 1.39M
HSIC Inventory
Cash effect of the change in inventory; building inventory consumes cash.
Henry Schein, Inc.NASDAQ: HSIC
Inventory · Q2 FY2026 · quarter ended Jun 2026
Inventory growth accelerates
Q2 FY2026 inventory of $57M (cash outflow) rose 280.0% year over year, ahead of the -41.0% change in trailing-twelve-month inventory. Over 3 fiscal years it compounded at -9.0% a year.
Context
- Inventory amounted to 0.7% of revenue in FY2025, up 0.3 pp from a year earlier.
- Inventory increased in 1 of the last 3 fiscal years.
What to watch
Whether quarterly growth of +280.0% holds above the trailing-twelve-month pace of -41.0%.
Sources:Cash FlowText generated from reported figures; not investment advice.
Inventory history
USD · from the cash flow
- Latest · FY2025
- (95M) USD
- Year-over-year change
- -61.0%
| Period | Period end | Inventory | YoY change |
|---|---|---|---|
| FY2025 | 2025-12-27 | (95M) | -61.0% |
| FY2024 | 2024-12-28 | (59M) | -125.5% |
| FY2023 | 2023-12-31 | 231M | +283.3% |
| FY2022 | 2022-12-31 | (126M) | +57.3% |
| FY2021 | 2021-12-31 | (295.13M) | — |
Inventory vs competitors
How HSIC compares with its peers on the latest reported figures
- HSIC's LTM Jun 2026 inventory of $115M is the 5th largest of the 7 companies compared; the peer median is $468.5M.
- Its year-over-year change of -41.0% is the 5th highest of 7, against a peer median of +58.9%.
- Inventory amounts to 0.8% of revenue for HSIC, versus a peer median of 0.4%.
| Company | Period | LTM | YoY | 3-year CAGR | % of revenue |
|---|---|---|---|---|---|
| LTM Jun 2026 | $1.33B | -16.8% | +24.0% | 0.4% | |
| LTM Jun 2026 | $1.19B | -689.6% | -4.9% | 0.3% | |
| LTM Sep 2026 | $923M | -50.7% | +5.8% | 0.4% | |
| LTM Mar 2026 | $276.89M | +204.3% | — | 10.2% | |
| LTM Jun 2026 | $115M | -41.0% | -9.0% | 0.8% | |
| LTM Mar 2026 | $14M | +250.0% | -50.6% | 0.4% | |
| LTM Oct 2026 | $6.7M | +134.5% | -10.0% | 0.2% | |
| Peer median (excluding HSIC) | $468.5M | +58.9% | -4.9% | 0.4% | |
Competitors are the stored peer set for HSIC. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Cash Flow Statement
Metric | FY2021 Dec 2021 | FY2022 Dec 2022 | FY2023 Dec 2023 | FY2024 Dec 2024 | FY2025 Dec 2025 |
|---|---|---|---|---|---|
| Net Income | 660.53M | 566M | 416M | 398M | 398M |
| Depreciation & Amortization | 209.53M | 212M | 222M | 268M | 311M |
| Deferred Income Tax | (12.93M) | (61M) | 0 | (56M) | 5M |
| Stock-Based Compensation | 78M | 54M | 39M | 39M | 0 |
| Change in Working Capital | (197.2M) | (281M) | (234M) | 140M | (48M) |
| Accounts Receivables | 4.16M | (7M) | (327M) | 315M | (124M) |
| Inventory | (295.13M) | (126M) | 231M | (59M) | (95M) |
| Accounts Payables | 84.71M | (96M) | 0 | (163M) | 216M |
| Other Working Capital | 9.06M | (52M) | (138M) | 47M | (45M) |
| Other Non-Cash Items | (28.34M) | 112M | 57M | 59M | 46M |
| Operating Cash Flow | 709.58M | 602M | 500M | 848M | 712M |
| Capital Expenditures | (79.02M) | (96M) | (187M) | (187M) | (139M) |
| Acquisitions (Net) | (560.8M) | (158M) | (955M) | (230M) | (276M) |
| Purchases of Investments | (7.32M) | (11M) | 0 | 0 | 0 |
| Sales of Investments | 7.32M | 11M | 22M | 4M | 0 |
| Other Investing Activities | (37.4M) | (22M) | (55M) | (56M) | (10M) |
| Investing Cash Flow | (677.22M) | (276M) | (1.14B) | (430M) | (477M) |
| Debt Repayment | 165M | 259M | 900M | 189M | 551M |
| Common Stock Issued | 0 | 0 | 0 | 0 | 252M |
| Common Stock Repurchased | (401M) | (485M) | (284M) | (385M) | (850M) |
| Dividends Paid | 0 | 0 | 0 | 0 | 0 |
| Other Financing Activities | (88.96M) | (57M) | 85M | (314M) | (64M) |
| Financing Cash Flow | (332.96M) | (315M) | 701M | (510M) | (111M) |
| Effect of Forex Changes | (2.63M) | (12M) | (12M) | 43M | (90M) |
| Net Change in Cash | (303.22M) | (1M) | 54M | (49M) | 34M |
| Free Cash Flow | 630.57M | 506M | 313M | 661M | 573M |
Henry Schein, Inc.
NASDAQ:HSIC
Intrinsic Alpha fair value
Locked
Current Price
$85.69
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.